Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced MyocarditisAlexi Vasbinder, Salim S. Hayek, Mohamad Fardous et al.|JACC CardioOncology|2022Cited by 78
Cardiovascular Events After Hematopoietic Stem Cell TransplantAlexi Vasbinder, Salim S. Hayek, Christopher W. Hoeger et al.|JACC CardioOncology|2023Cited by 46
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyKerry Skurka, Diego Sadler, Jeanne M. DeCara et al.|Cardio-Oncology|2020Cited by 28
Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomesAlexander M. Balinski, Salim S. Hayek, Alexi Vasbinder et al.|Cancer Medicine|2022Cited by 28
Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE‐BMT Risk ScoreAlexi Vasbinder, Salim S. Hayek, Tonimarie Catalan et al.|Journal of the American Heart Association|2023Cited by 25